Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tanglong, officially Gansu Tanglong Pharmaceutical, is a prominent Chinese pharmaceutical company and a key subsidiary of Lanzhou Foci Pharmaceutical. Based in Lanzhou, the company is a leader in the modernization of Traditional Chinese Medicine (TCM), specializing in the production of concentrated pills, tablets, and capsules. Its extensive product portfolio covers therapeutic areas such as respiratory health, gastroenterology, and cardiovascular care, with well-known products like Liuwei Dihuang Wan. Tanglong operates advanced manufacturing facilities that meet national GMP standards and is dedicated to integrating traditional herbal formulas with modern scientific research. The company plays a significant role in both the domestic Chinese market and international herbal medicine exports, reaching markets in Southeast Asia, North America, and Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tanglong.